Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | AZN | AMGN | GILD | BMY |
| Company | Prometheus Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 199.68 | 198.89 | 354.90 | 139.69 | 61.21 |
| High | 199.98 | 201.74 | 357.00 | 141.49 | 62.23 |
| Low | 199.60 | 198.72 | 351.66 | 138.82 | 60.87 |
| Latest | 199.92 | 200.73 | 353.28 | 140.30 | 61.73 |
| Change | +0.18 | +3.51 | +1.43 | +0.93 | +1.08 |
| % Change | +0.09% | +1.78% | +0.41% | +0.67% | +1.78% |
| Volume | 1,860,600 | 2,158,600 | 2,726,700 | 5,286,400 | 9,881,800 |
| 20-Day Average Volume | 1,174,595 | 1,869,385 | 2,734,835 | 6,249,765 | 13,768,625 |
| Previous Close | 199.74 | 197.22 | 351.85 | 139.37 | 60.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 191.11 | 359.30 | 141.53 | 59.38 |
| 20-Day Raw Stochastic | 99.23% | 94.78% | 23.67% | 41.38% | 91.43% |
| 20-Day Relative Strength | 81.45 | 57.90 | 46.34 | 48.67 | 59.79 |
| Weighted Alpha | +110.70 | +47.21 | +22.34 | +32.23 | +23.44 |
| Today's Opinion | 100% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | +7.26% since 03/25/26 | -0.18% since 03/25/26 | +1.48% since 03/25/26 | +4.73% since 03/25/26 |
| Low | 198.91 on 06/09/23 | 182.79 on 03/26/26 | 347.11 on 03/31/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 199.98 on 06/15/23 | 201.74 on 04/01/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | -3.70% since 02/27/26 | -8.99% since 02/27/26 | -5.81% since 02/27/26 | -1.03% since 02/27/26 |
| Low | 189.76 on 05/16/23 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 199.98 on 06/15/23 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +9.18% since 12/31/25 | +7.93% since 12/31/25 | +14.31% since 12/31/25 | +14.44% since 12/31/25 |
| Low | 104.55 on 03/30/23 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 199.98 on 06/15/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +18.97% since 10/01/25 | +18.35% since 10/01/25 | +26.23% since 10/01/25 | +30.15% since 10/01/25 |
| Low | 103.33 on 01/06/23 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 199.98 on 06/15/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 305,870,048 | 189,671,072 | 172,989,120 | 123,831,232 |
| Shares Outstanding, K | 47,813 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 6,810,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -141,750,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,110,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -40,880,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.49 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 08/10/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.17 | 15.97 | 16.73 | 9.71 |